Stay updated on CABozantinib in NSCLC MET Clinical Trial

Sign up to get notified when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CABozantinib in NSCLC MET Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The revision number changes from v3.6.5 to v3.6.6, indicating a small update to the page. This update appears to affect backend or formatting aspects rather than the study content.
    Difference
    0.0%
    Check dated 2026-08-29T23:45:15.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A new revision label, v3.6.5, has been applied, replacing the previous v3.6.4. This update appears to be a routine site maintenance or software/version bump and does not indicate changes to the study text, eligibility criteria, or participant information.
    Difference
    0.0%
    Check dated 2026-08-08T19:39:59.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4 on the page. It represents a small backend/frontend update without altering displayed study details.
    Difference
    0.0%
    Check dated 2026-07-25T12:36:39.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This appears to be a backend or formatting update and does not modify study details or public content.
    Difference
    0.0%
    Check dated 2026-07-03T23:57:01.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2, indicating a software/content management update to the page rather than changes to study details.
    Difference
    0.0%
    Check dated 2026-06-26T22:50:40.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    New guidance sections were added to the study record (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was standardized. Older labels such as Verified and Last known status was: were removed or updated to Revision: v3.6.0, with new fields Last verified and Last known status was added.
    Difference
    1%
    Check dated 2026-06-12T12:16:01.000Z thumbnail image

Stay in the know with updates to CABozantinib in NSCLC MET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.